LifeTech Capital Recommends NovaBay Pharmaceuticals
Written on Jan 31, 2010
Investment research firm LifeTech Capital has recommended another biotech stock, reports Mike Havrilla of Seeking Alpha. Stephen Dunn of LifeTech rated NovaBay Pharmaceuticals a “strong speculative buy.” NovaBay of Emeryville, Calif., develops antimicrobial products for a variety of infections,...
Sinus Patients May Benefit from Surgery, Study Finds
Written on Jan 30, 2010
Like a relentless opponent in a boxing match, sinus infections refuse to stay down for long. Bombard them with antibiotics, blast them with nasal sprays, attack them with hot compresses and decongestants–sinus infections have a way of returning full-force to inflict more misery. Sinusitis, or...
Diabetes Drug Wins Approval, Helps the Competition
Written on Jan 29, 2010
The approval of Novo Nordisk‘s diabetes drug Victoza has led to an unintended benefit for a competitor. On Tuesday, the Danish company announced that the U.S. Food and Drug Administration approved Victoza (liraglutide) for the treatment of Type 2 diabetes. The news fueled optimism that a similar drug...
ImmunoCellular Therapeutics at the 2010 OneMedForum
Written on Jan 29, 2010
Manish Singh, President and CEO of ImmunoCellular Therapeutics, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San...
Sword Diagnostics at the 2010 OneMedForum
Written on Jan 29, 2010
David Dingott, President and Founder of Sword Diagnostics, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San...
Cleveland BioLabs at the 2010 OneMedForum
Written on Jan 29, 2010
Michael Fonstein, President and CEO of Cleveland BioLabs, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San...
Facet Solutions at the 2010 OneMedForum
Written on Jan 29, 2010
Geoff Pardo, President and CEO of Facet Solutions, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum...
Immunomic Therapeutics at the 2010 OneMedForum
Written on Jan 29, 2010
Dr. William G. Hearl, CEO of Immunomic Therapeutics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San...
